Año
Autores / Publicación
Millán Gómez, D. V., Dueñas Espinoza, S., Muñoz, P. L. A., Camacho Villegas, T. A., Elosua, C., Cabanillas Bernal, O., Escalante, T., Almudena, P., Abia, D., Drescher, F. C. L., Fournier, P. G. J., Ramos Ibarra, M. A., Mares, R. E., Paniagua Solís, J. F., Mata González, M. T., Gonzalez Canudas, J., Hoffman, R., Licea Navarro, A. F., & Sánchez Campos, L. N. (2018). In silico-designed mutations increase variable new-antigen receptor single-domain antibodies for VEGF165 neutralization. Oncotarget, 9(46), 28016-28029. doi: 10.18632/oncotarget.25549. (ID: 23951)
Jain, A., Fournier, P. G. J., Mendoza, v., Sengar, P., Guerra Olvera, F. M., Iñiguez Pacheco, J. E., Kretzschmar, T. G., Hirata Flores, G. A., & Juárez Camacho, P. (2018). Functionalized rare earth-doped nanoparticles for breast cancer nanodiagnostic using fluorescence and CT imaging. JOURNAL OF NANOBIOTECHNOLOGY, 16(1), 26. doi: 10.1186/s12951-018-0359-9©. (ID: 23640)
Sengar, P., Juárez Camacho, P., Verdugo Meza, A. A., Arellano Rodríguez, D. L., Jain, A., Chauhan, K., Hirata Flores, G. A., & Fournier, P. G. J. (2018). Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy. JOURNAL OF NANOBIOTECHNOLOGY, 16, 19. doi: 10.1186/s12951-018-0344-3. (ID: 23609)
Juárez Camacho, P., Fournier, P. G. J., Mohammad, K., McKenna, R., Davis, H., Peng, X., Niewolna, M., Mauviel, A., Chirgwin, J., & Guise, T. (2017). Halofuginone inhibits TGF-ß/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis. Oncotarget, 8(49), 86447-86462. doi: 10.18632/oncotarget.21200. (ID: 22561)
Trivedi, T., Zheng, Y., Fournier, P. G. J., Murthy, S., John, S., Schillo, S., Dunstan, C. R., Mohammad, K., Zhou, H., Seibel, M. J., & Guise, T. (2017). The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm. Oncotarget, 8(16), 26687-26701. doi: 10.18632/oncotarget.15803. (ID: 22456)